COVID-19 Vaccines

All categories
Name
COVID-19 Vaccines
Accession Number
DBCAT005462
Description

Vaccines or candidate vaccines containing SARS-CoV-2 component antigens, genetic materials, or inactivated SARS-CoV-2 virus, and designed to prevent COVID-19.

ATC Classification
Drugs
DrugDrug Description
TozinameranAn mRNA vaccine for the prevention of COVID-19 caused by the SARS-CoV-2 virus.
Moderna COVID-19 VaccineAn mRNA vaccine for the prevention of COVID-19 caused by the SARS-CoV-2 virus.
Janssen COVID-19 VaccineAn adenovirus-based vaccine used for active immunization against COVID-19 caused by SARS-CoV-2 infection.
NuvaxovidA recombinant spike (S) protein vaccine for the prevention of COVID-19 caused by SARS-CoV-2.
AstraZeneca COVID-19 VaccineA two-dose replication-deficient adenovirus vector vaccine used to prevent COVID-19 caused by SARS-CoV-2.
BNT162b1 SARS-CoV-2 VaccineBNT162b1 is one of four advanced mRNA-based vaccines being developed through "Project Lightspeed," a joint program between Pfizer and BioNTech.[L15002, L15007] BNT162b1 is a nucleoside modified mRNA (modRNA) vaccine encoding...
PidacmeranPidacmeran is under investigation in clinical trial NCT04380701 (A Trial Investigating the Safety and Effects of Four BNT162 Vaccines Against COVID-2019 in Healthy Adults).
BNT-162A1BNT-162A1 is under investigation in clinical trial NCT04380701 (A Trial Investigating the Safety and Effects of Four BNT162 Vaccines Against COVID-2019 in Healthy Adults).
Plant-based virus-like particles, recombinant, adjuvanted COVID-19 vaccineA vaccine comprising purified SARS-CoV-2 spike protein expressed in plant-based virus-like particles for the prevention of COVID-19 in adult patients.
DavesomeranAn mRNA vaccine in combination with the Moderna COVID-19 vaccine to prevent infection from the Omicron variant of the SARS-CoV-2 virus in people 6 years old or older.
FamtozinameranA component of a bivalent COVID-19 mRNA vaccine encoding the viral spike protein of Omicron variant lineages BA.4 and BA.5.
ImelasomeranA component of a bivalent COVID-19 mRNA vaccine encoding the viral spike protein of Omicron variant lineage BA.1.
RiltozinameranA component of a bivalent COVID-19 mRNA vaccine encoding the viral spike protein of Omicron variant lineage BA.1.
AndusomeranAn mRNA vaccine for the prevention of COVID-19 caused by the SARS-CoV-2 virus, including the XBB.1.5 subvariant.
SARS-CoV-2 virus recombinant spike (S) protein receptor binding domain (RBD) fusion heterodimer (B.1.351-B.1.1.7 strains)A recombinant non-mRNA COVID-19 vaccine.
VidPrevtyn BetaA recombinant, adjuvanted DNA vaccine given as a booster dose to prevent COVID-19.
Drugs & Drug Targets
DrugTargetType